Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amélie Boutin, PhD
CHU de Québec-Université Laval
Principal Investigator - Andrew J. McPhee, MB, BS
South Australian Health and Medical Research Institute
Principal Investigator - Carmel T. Collins, PhD
South Australian Health and Medical Research Institute
Principal Investigator - David Simonyan, MSc
CHU de Québec-Université Laval
Principal Investigator - Etienne Pronovost, BSc
CHU de Québec-Université Laval
Principal Investigator - Ibrahim Mohamed, MD, PhD
St. Justine's Hospital
Principal Investigator - Isabel Fortier, PhD
Research Institute of the McGill University Health Centre
Principal Investigator - Isabelle Marc, MD, PhD
CHU de Québec-Université Laval
Principal Investigator - Jacqueline F. Gould, PhD
South Australian Health and Medical Research Institute
Principal Investigator - Lynne Moore, PhD
Laval University
Principal Investigator - Marc Beltempo, MD
McGill University Health Centre/Research Institute of the McGill University Health Centre
Principal Investigator - Maria Makrides, PhD
South Australian Health and Medical Research Institute
Principal Investigator - Mireille Guillot, MD
CHU de Québec-Université Laval
Principal Investigator - Pascal M. Lavoie, MD, PhD
University of British Columbia
Principal Investigator - Thomas R. Sullivan, PhD
South Australian Health and Medical Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu de Québec-Université Laval
Québec, Quebec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jul 2023
- Primary completion
- 15 Nov 2023
- Completion
- 31 Mar 2026
- Last update posted
- 14 Jul 2025
- Registered enrollment
- 1,801
- Registry id
- NCT05915806
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.